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1. Introduction 
Pulmonary hypertension (PH) in modern genetic strains of chicken broilers is a world wide 
distributed entity, which has a recognized economical impact (Maxwell et al., 1997; Pavlidis 
et al., 2007). Also, the commercial chicken has been a model to study PH in man, because 
encountered pathological changes in that animal closely resemble the human condition. 
Under natural atmospheric conditions, two determining causes for PH are known: 
hypobaric hypoxia and low temperatures exposure (i.e. birds exposure to temperatures 
below 16º C (Pakdel et al., 2005; Pan et al., 2005).  
The incidence and clinical evolution of PH in various strains of commercial chickens 
maintained under a natural hypoxic tropical environment in the Bogotá plane at 2638 m 
above sea level (masl) have been evaluated over several years, using direct observation of 
animals, electrocardiography, morphometric studies, hematocrit and hemoglobin changes, 
histochemical, immunohistochemical and molecular procedures. 
Morphometric cardiac and pulmonary changes allowed in post-mortem studies to define mass 
cardiac index values (CI) to differentiate non-pulmonary hypertensive chickens (NPHC) from 
the pulmonary hypertensive ones (PHC) (Hernández, 1982, 1987; Cárdenas et al., 1985; Areiza, 
2010, Vásquez, 2010). CI is defined as the right ventricular muscle mass weight expressed as a 
percentage of the total ventricular muscle weight (Alexander and Jensen, 1959). It is now clear 
that PHC have a CI value of 25 and higher and, below 22, birds can be safely allocated in the 
NPHC group (Gómez et al., 2007; Areiza, 2010; Vásquez, 2010). The remodeling process of 
pulmonary arterioles has been studied by morphometric analysis of smooth muscle and 
adventitia layers in PHC (Useche et al., 1981 Sandino and Hernández, 2005). 
Electrocardiography was found to have a predictive value to define which animals would 
develop PH. Also, it determined that there is not a defined time course in the evolution of PH 
in chickens. The latter has been corroborated with daily field observations (Pulido, 1996). 
Several studies showed that low temperatures and pulmonary diseases have an enhancing 
effect in the occurrence of PH (Mejía, 1982; Hernández, 1984).  
Hypobaric hypoxia and low temperature are determinants of PH occurrence in the pulmonary 
vasculature of broilers. Sensitivity is species dependent and the domestic chicken appears to be 
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most prone to develop that condition, whereas South American camelids and the bovine yak 
are highly resistant, among studied species. Man is believed to occupy a low place in this 
context (Grover et al., 1983; Monge and León-Velarde, 1991). However, there is a genetic 
component within species, which is responsible for susceptibility or resistance, as seen in 
human native Tibetans and the bovine yak (Durmowicz et al., 1993; Moore et al., 1998). The 
bar-headed goose and the Himalayan domestic chicken are well adapted avian species to 
altitudes above 3000 masl. The bar-headed goose can reach altitudes of 9000 masl (Graham 
and Milsom, 2007). The modern broiler chicken´s strains also differ in their susceptibility 
(Hernández, 1982; Huchzermeyer et al, 1988).  
There is a large amount of scientific data which give capital importance to the energy 
density of feed as causative of PH, but, at least under low altitude and respiratory healthy 
conditions, commercial chickens do not develop PH (Useche et al., 1981, Cárdenas et al, 
1985; Gómez et al, 2007; Vásquez, 2010). Nevertheless, the energy content is in fact an 
undeniable adjuvant factor to increase incidence of PH when low temperatures and/or 
hypobaric hypoxia are present, although its mechanism has not been clearly elucidated 
(Tarquino et al., 1990). Interesting theories and well carried studies have been advanced, 
which include thyroid hormones metabolism (hypothyroidism) and hypoxemia (Camacho-
Fernández et al, 2002; Hassanzadeh et al., 2005), but they do not focus on the principal issue 
which is pulmonary vasoconstriction due to low temperature and/or hypobaric hypoxia. In 
fact, they attribute PH to a metabolic disarrangement which results in hypoxemia. Another 
element to enhance or probably cause PH, most likely through hypoxia, is the presence of 
pulmonary obstructive diseases (Huchzermeyer et al., 1987; Guzmán et al., 2001), which are 
common entities in the broiler´s industry nowadays. 
It is important to note that when both temperature and energy density of feed are controlled, 
hypobaric hypoxia per se is sufficient to cause PH (Tarquino et al, 1990; Vásquez, 2010). 
2. Compensatory mechanisms and development of PH 
Elevation of pulmonary artery pressure is an immediate response to hypobaric hypoxia. If 
the level of this increment is maintained above physiological limits, that is, in susceptible 
(non- adapted) individuals, PH ensues (Cueva et al., 1974). From there on, cardiac output is 
maintained due to ventricular adaptation to high pulmonary vascular resistance. There is 
right ventricular mass increment through hypertrophy and hyperplasia (Bernal et al., 1984) 
and the II Q wave in electrocardiographic readings becomes progressively more negative, 
until ventricular dilatation determines cardiac failure (table 2). This process does not have a 
defined time pattern and may begin as early as 10 days post-hatching, ranging from 4 to 20 
days (Pulido, 1996). 
Another compensatory mechanism is augmentation of hematocrit (Ht) and hemoglobin 
(Hb) content (Table 2; Cárdenas et al, 1985; Colmenares et al, 1990). Hypoxia induces the 
expression of the hypoxia inducible factor 2 (HIF-2) which stimulates renal secretion of 
erythropoietin by cortical fibroblasts in the kidney, a molecule responsible for hematocrit 
increment, by diminishing apoptosis in erythrocyte progenitor cells (Paliege et al., 2010). As 
a consequence, blood viscosity is augmented, a change believed to increase resistance in the 
pulmonary vasculature, which can be considered as an aggravating factor in the 
development of PH. One compensatory mechanism is increased hemoglobin affinity for 
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oxygen, as exhibited by well adapted avian species such as the bar headed and Andean 
geese as well as the Tibetan chicken (Weber et al. 1993, Zhang et al, 2007). 
Hypoxemia results from low pO2 in the air spaces in the lung (alveoli in mammals and 
respiratory capillaries in avian species). Oxygen and carbon dioxide low blood pressure 
sensing structures such as the carotid cell bodies (Lahiri et al., 2006), intrapulmonary and 
peripheral neural receptors elicit a rise in respiratory rate through vagal neural efferent 
inputs originated in neural respiratory centers (Glogowska et al., 1972). 
3. Gross and light microscopic changes in pulmonary hypertension 
The lungs appear congested, but no signs of edema are evident as known to occur in 
mammals. Microscopically, the most prominent finding relates to the engrossment of the 
medial muscle layer in arterioles (figures 9 and 10). This subjective appreciation has been 
thoroughly corroborated by morphometric methods in several studies (Sillau and Montalvo, 
1982; Useche et al., 1981, Moreno de Sandino and Hernández, 2006). Cartilage and/or bone 
neo-formations can be seen in variable amounts within the pulmonary parenchyma (figure 
3), together with fibrosis of the adventitial layer of arterioles. The degree of fibrosis varies 
(figure 2). Muscle hypertrophy is also found in peribronchial walls (Dalmau, 1997). 
Atelectasia can be encountered in many areas of the lung.  
 
Fig. 1. Pulmonary hypertensive chicken. Ascites 
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In the heart, different degrees of right ventricular dilatation are present, which are 
presumably connected to the severity of PH. The increase in ventricular mass weight is due 
to both hyperplasia and hypertrophy (Bernal et al, 1984). No signs of vascular changes in the 
heart are detected, as seen with the light microscope. 
As a result of right ventricular insufficiency secondary to increased pulmonary vascular 
resistance, detention of returning venous blood becomes increasingly difficult. Hence, 
generalized passive congestion is evident, which includes portal congestion. Ascites results 
from plasma leaking from the congested liver (Figure 1). Liver hypertrophy is a common 
finding in necropsies. Microscopically, some degree of fibrosis and sinusoidal dilatation can 
be seen.  
In most cases of PH, hydropericardium is encountered. Some individuals may die with this 
lesion, and absence of ascites. Furthermore, a few animals die with none of the 
abovementioned lesions. The latter cases probably correspond to more susceptible individuals.  
              
Fig. 2. Lung fibrosis (left). Pulmonary hypertensive chicken. Lung from a non-pulmonary 
hypertensive chicken (right). Masson´s trichromic stain 
 
Fig. 3. Fibrosis and bone neo-formation. Pulmonary hipertensive chicken Masson’s 
trichromic stain 
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Altitude
m above sea 
level
Hemoglobine
g/100 mm 
Hematocrit
% PVC 
Red blood cells
millions/cc * 
Mean SD Mean SD Mean SD 
225 8.54 1.26 27.30 2.88 4.72 0.97 
2638
NPHC
10.82 1.36 33.91 3.15 4.40 0.71 
2638 
PHC
13.15 2.30 40.10 8.30 2.43 1.31 
 
SD: standard deviation. NPHC and PHC: non-pulmonary and pulmonary hypertensive chickens 
* Red blood cells values should be multiplied by 10000 
Cárdenas et al., 1985. 
Table 1. Hemoglobine, hematocrit and red blood cells counts in healthy and pulmonary 
hypertensive broilers maintained under normoxia and hypobaric hypoxia 
 
L(II) s (- mV) values at different age ranges (in days) 
8-10 15-17 22-24 29-31 36-41 
days 
CI D 
0.20 0.40     35.2  15 
0.35     42.9  17 
0.40 0.40    38.5  22 
0.10 0.30    37.5  22 
0.30 0.20    33.3  22 
0.05 0.15 0.30   38.7  22 
0.35 0.60 0.65   41.7  23 
0.30 0.60 0.65   36.4  23 
0.15 0.40    37.5  24 
0.25 0.25 0.50   34.8  29 
0.15 0.25 0.60 0.80  37.0  30 
0.35 0.60 0.75   40.0  30 
0.10 0.10 0.20 0.50  36.2  30 
0.25 0.15 0.45 0.65  37.5  31 
0.30 0.10 0.50 1.00  48.9  31 
0.20 0.20 0.30 0.50  0.90 40.5  37 
0.30 0.40 0.30 0.35  35.4  37 
0.20 0.10 0.20 0.25  0.30 41.3  41 
CI= cardiac mass index. D= age-day of spontaneous animal´s death. Data taken and modified from 
Pulido, 1996 
Table 2. Electrocardiographic wave 2. derivative II [L (II)s] (mV) and cardiac mass index in 
pulmonary hypertensive chickens  
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4. Pathogenesis 
As already stated, chronic exposure to hypoxia leads to PH due to pulmonary 
vasoconstriction, structural remodeling of pulmonary vessels and increased blood viscosity 
in mammals and chickens (Bartsch et al., 2005; Burton and Smith, 1967; Burton et al., 1967; 
Cueva et al., 1974; Currie, 1999; Cogo et al., 2004; Huchzermeyer, 1988; Kanazawa et al., 
2005; Meyrick and Reid, 1978; Remillard and Yuan, 2005; Reeves and Grover, 2005; Rhodes, 
2005). Pulmonary vascular resistance is enhanced by constriction of pulmonary vascular 
smooth muscle and structural remodeling of the vascular bed (Reid, 1979; Stenmark and 
Mecham, 1997). 
The pathogenesis of PH involves a complex and multifactorial process. Vasoconstriction and 
remodeling of the pulmonary vessel wall contribute to increased pulmonary vascular 
resistance in PH (Voelkel et al., 1997). Hypoxic pulmonary vasoconstriction (HPV) is an 
important physiological property of the pulmonary circulation and can optimize the 
ventilation: perfusion ratio by diverting blood away from poorly ventilated areas of the 
lung. However, in global hypoxia, which is found in high altitude environments, HPV 
results in a rise in pulmonary vascular resistance (PVR) and concomitant PH. This severely 
increases the afterload on the right heart and, in combination with associated pulmonary 
vascular remodelling, leads to a right ventricular dilatation and heart failure. Sustained 
vasoconstriction in response to moderate hypoxia is unique to the pulmonary vasculature. 
In despite of the progress made from many studies, the precise mechanisms involved are 
elusive. Recent advances in the field have opened up new areas of investigation, particularly 
in regard to the role of the vascular endothelium. 
The first modern observation of HPV was made in 1894 when Bradford and Dean (1894) 
described increases in pulmonary arterial pressure (PAP) in response to asphyxia. Half a 
century later, HPV was recognized as an adaptive phenomenon by von Euler and 
Liljestrand (1946). They ventilated anesthetized cats with either hypoxic (10% O2) or 
hypercapnic gas mixtures and found that PAP increased, with minimal change in left 
atrial pressure, predominantly with the hypoxic challenge. They concluded that HPV 
might "increase the blood flow to better aerated lung areas, which leads to improved 
conditions for the utilization of alveolar air". HPV shunts blood from poorly oxygenated 
areas to better ventilated lung segments, thereby optimizing ventilation-perfusion 
matching, reducing shunt fraction and optimizing systemic O2 delivery in conditions such 
as atelectasis and pneumonia (Brimioulle et al, 1996). HPV onsets within seconds of 
moderate hypoxia and reverses quickly on restoration of normoxic ventilation. Whereas, 
in pneumonia and atelectasis, HPV is a focal response limited to the diseased lung 
segment, with global hypoxia, as occurs at high altitude or with sleep apnea, HPV 
constricts PAs throughout the pulmonary circulation, increasing the PVR (Moudgi et al., 
2005).  
Vasoconstriction in response to hypoxia can occur in isolated pulmonary arteries, which 
leads to the conclusion that the oxygen sensor and subsequent constrictor mechanism(s) 
must be located in either the vascular smooth muscle or the endothelium. The discovery of 
K+ channels that are depressed by hypoxia in pulmonary, but not systemic vascular smooth 
muscle cells, has provided a potential signal mechanism of transduction, which permits to 
propose a link between reduction in alveolar PO2, depolarization of the cell membrane, and 
contraction via voltage-gated Ca2+ entry (Post et al., 1992). Several reports have also shown 
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that hypoxia can cause shortening in isolated pulmonary arterial smooth muscle cells 
(Madden et al., 1992) and this suggests that HPV is a function of the smooth muscle rather 
than the endothelium. However, other studies have shown that the endothelium is 
definitely required for sustained vasoconstriction (Demiryurek et al., 1993; Leach et al., 1994; 
Zhang and Morice, 1994). Although some differences in response might be ascribed to 
variations among species and variations in artery size (Leach et al.1994), a possibly more 
important aspect is the time course over which the experiment is conducted. 
Most reports, in particular those on isolated cells, describe processes that occur during the 
first 10-15 min. However, isolated pulmonary arteries show a biphasic response to hypoxia 
when observed over longer periods (Bennie et al., 1991; Leach et al. 1994; Zhang and Morice, 
1994; Robertson et al., 1995). This biphasic response consists of a rapid, transient increase in 
vascular tone over about 5-10 min (phase 1), which then falls towards the baseline. This is 
followed by a more slowly developing but sustained increase in tone (phase 2), which 
reaches a plateau about 40 min later on. The phase 1 of constriction is relatively unaffected 
by removal of the endothelium, while in most reports phase 2 is abolished (Hoshino et al., 
1994; Leach et al. 1994; Zhang and Morice, 1994).  
The relative physiological significance of the abovementioned phases is opened to question. 
Although HPV in vivo or in blood-perfused lungs is generally characterized by a rapid rise 
in pulmonary vascular resistance, this increase in resistance is sustained for long periods. It 
would seem most likely, therefore, that the second sustained phase of constriction in 
isolated arteries is more relevant to physiological HPV than the transient first phase. In the 
whole lung the effects may result in a rapid but sustained increase in resistance. The 
biphasic response to hypoxia suggests that HPV involves multifactorial mechanisms, which 
may or may not be interdependent.  
HPV is intrinsic to the lung and, although modulated upstream by the endothelium and 
downstream by calcium sensitization of the contractile apparatus (rho kinase), the core 
mechanism involves a redox-based O2 sensor (likely the mitochondria) that generates a 
diffusible redox mediator (likely H2O2) that is withdrawn during hypoxia, leading to 
hypoxic inhibition of certain voltage-gated K+ channels (Kv) in pulmonary artery smooth 
muscle cells (PASMCs). Specific O2-sensitive Kv channels, including Kv1.5 and Kv2.1, set 
membrane potential (EM) and thus control Ca2+ influx, via voltage-gated Ca2+ channels, and 
therefore vascular tone (Moudgi et al., 2005).  
Substantial work defining the properties of HPV has been performed by integrative 
physiologists studying normal and diseased humans. Ignorance of this integrative 
physiology and overreliance on reductionist models, using vascular cells and rings have 
created confusion in the quest for the molecular mechanism of HPV. In addition, because 
HPV is elicited by moderate airway hypoxia, rather than anoxia or low mixed- venous pO2, 
it is worthwhile to define "hypoxia" as it pertains to HPV. Ascent to the summit of Mount 
Everest defines the limit of hypoxia tolerated by humans and thus serves as a practical guide 
to what constitutes "physiologically relevant" hypoxia. At the summit of Mount Everest, the 
inspired and arterial PO2 values are approximately 43 Torr, whereas the arterial pCO2 is 11 ± 
2 Torr and arterial pH is 7.53 (Malconian et al., 1993). 
HPV increases PVR by 50-300%. The response to hypoxia onsets in minutes, reaching a 
maximum within 15 min (Bindslev et al., 1985). In normal volunteers, inhalation of 12.5% O2 
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decreases systemic pO2 to below 50 Torr and increases PVR by 100–150% (Moore et al., 
1998). HPV is not potentiated by repeated hypoxic challenges, nor does it decrease when 
sustained for hours (Dorrington et al., 1997). An interesting case report attests to the 
potential of segmental HPV to persist chronically. A patient with bronchial obstruction due 
to an adenoma had persistent, HPV-induced lung hypoperfusion that was normalized by 
resection of the tumor and restoration of distal airflow (Grant et al., 1980).  
In an excellent demonstration that HPV depends on airway and not mixed-venous PO2, 
unilateral graded hypoxia (12–5% inspired O2) was delivered while the contralateral lung 
received 100% O2. This reduced the perfusion of the hypoxic lung from a normoxic value of 
52 ± 2 to 30 ± 8% of total lung flow, without a significant fall in mixed-venous PO2 
(Hambraeus-Jonzon et al., 1997). In healthy volunteers, 8 h of hypoxia increased PVR from 
1.2 ± 0.3 to 2.9 ± 0.3 Wood Units at 2 h and thereafter PVR remained constant, reversing on 
return to normoxia (Dorrington et al., 1997). Systemic vascular resistance (SVR) decreased in 
parallel. The intrinsic nature of these opposing responses to hypoxia is demonstrated by the 
ability to demonstrate simultaneous HPV and renal vasodilatation in the isolated, serially 
perfused lung-kidney model and even in isolated arterial rings (Michelakis et al., 2002). HPV 
also occurs in children. In a study of children with congenital heart disease, mild hypoxic 
ventilation (15% inspired O2) increased the PVR/SVR ratio from 0.33 to 0.40 (Waldman et 
al., 1983).  
If alveolar pO2 is maintained above 60 Torr, there is a little pulmonary vasoconstriction to 
hypoxemia, even when mixed- venous pO2 is reduced to 10 Torr (Marshall and Marshall, 
1983), confirming that alveolar O2 tension, not blood PO2, is the major determinant of HPV. 
Micropuncture studies confirm that the small resistance PAs (<200 µm) are directly exposed 
to the alveolar PO2 and are the major site of HPV (Kato and Staub,1966). HPV can be 
demonstrated in salt-perfused isolated lungs (McMurtry et al., 1976) and resistance PA rings 
denuded of endothelium (Archer et al., 2004). Indeed, isolated pulmonary artery smooth 
muscle cell (PASMC) from resistance pulmonary arteries (PAs) constrict to hypoxia. In 
contrast, smooth muscle cells (SMCs) from carotid arteries or even conduit PAs do not 
constrict to hypoxia (Madden et al., 1992). This demonstrates that HPV is unique to the PA, 
particularly the resistance segment of the pulmonary circulation. As in humans, hypoxia 
dilates most systemic arteries in animals (Hampl et al., 1994). 
The persistence of global hypoxia ultimately results in a selective downregulation of acute 
HPV, despite the occurrence of PH and the finding that constrictor responses to other 
stimuli are preserved or enhanced (Durmowicz et al., 1993; Reeve et al., 2001). Exposure to 
hypoxia for only 3 h can elicit this selective suppression of HPV (Greenlees and 
Tucker,1984). Animals and humans genetically adapted to life at high altitude, such as the 
yak (Durmowicz et al., 1993) or the native Tibetan (Moore et al., 1998) have weak or absent 
HPV.  
The vascular endothelium is known to produce a wide range of active compounds, including 
various vasodilators and vasoconstrictors. Vasoconstriction could result from either a 
reduction in vasodilator activity or an increase in vasoconstrictor activity; several possible 
mediators have been examined, including nitric oxide (NO), cyclooxygenase and lipoxygenase 
products, endothelin-1 (ET-1) and serotonin. There is disagreement about the nature of HPV in 
isolated PA rings. In animals, HPV causes a rapid increase in PVR that gradually reaches a 
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plateau and is sustained, much as occurs in humans. However, in isolated PA rings, some 
research groups find that HPV is biphasic, consisting of an immediate, endothelium-
independent constriction, which peaks in 10 min (phase I) and a second, slowly developing 
endothelium-dependent sustained contraction that peaks at 40 min (phase II) (Ward and 
Robertson, 1995). On the other hand, Archer et al., 2001 consistently found a monophasic PA 
constriction in resistance PA rings, even if they are denuded of endothelium. They believe that 
the role of the endothelium is to modulate HPV. Nitric oxide (NO), produced in response to 
pulmonary vasoconstriction, suppresses HPV. Endothelin-1 (ET-1), produced in response to 
hypoxia, enhances HPV (Platoshyn et al., 2000).  
One of the problems associated with such examinations is that the release of many of these 
vasoactive agents is affected by the vascular tone, so that it may be difficult to determine 
whether changes in a particular agent are due to the enhanced vasoconstriction during 
hypoxia, or to hypoxia per se (Ignarro, 1990; Inagami et al, 1995). 
4.1 Molecular mechanisms of pulmonary hypertension 
It is now well known that, under physiological conditions, the vascular endothelium 
produces factors that maintain normal vascular tone and homeostasis. Two of the most 
important factors produced by the vascular endothelium are the endothelium-derived 
relaxing and antiproliferative factor NO, and the endothelium-derived vasoconstrictor and 
mitogenic factor endothelin-1 (ET-1) (Moncada et al., 1991; Yanagisawa, 1994). The 
interactions between NO and ET-1 in the control of vascular tone have been extensively 
studied (Lavallee et al., 2001). 
Pulmonary vasoconstriction is believed to be an early component of the pulmonary 
hypertensive process. Excessive vasoconstriction has been related to abnormal function of 
expression of potassium channels, as well as to endothelial dysfunction. Endothelial 
dysfunction seems to play an integral role in alveolar hypoxic vasoconstriction. The 
endothelium mediates the structural changes in the pulmonary vasculature, which includes 
an altered production of various endothelial vasoactive mediators, such as NO, prostacyclin, 
endothelin-1 (ET-1), serotonin, and thromboxane. Endothelial dysfunction leads to 
chronically impaired production of vasodilators such as NO and prostacyclin along with 
prolonged over expression of vasoconstrictors such as ET-1. These changes affect vascular 
tone and promote vascular remodeling. Given that most of these mediators affect the growth 
of smooth muscle cells, an alteration in their production may facilitate the development of 
pulmonary vascular hypertrophy and the structural remodeling characteristic of pulmonary 
hypertension (Budhiraja et al., 2004; Humbert et al., 2004). 
4.1.1 Nitric oxide 
Originally identified as the reactive intermediate by which nitroprusside caused smooth 
muscle cell relaxation, it was not until nitric oxide (NO) was identified as the endothelium-
derived relaxing factor that its role was explored in PH (Gruetter et al., 1979; Ignarro, 1989). 
NO was found to be a critical vasodilator that could also inhibit platelet aggregation and 
proliferation of vascular smooth muscle cells. Human studies reported variable production 
of NO in patients with idiopathic pulmonary arterial hypertension (IPAH). However, 
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important mechanistic insights into the role of NO in the control of pulmonary vascular tone 
and remodeling originated from animal models, which showed NO-mediated protection 
against HPV in lungs, inhibition of smooth muscle proliferation and platelet aggregation, 
and downregulation of ET-1 production (Perrella et al., 1992). NO has broader effects in that 
it contributes to angiogenesis, endothelial cell survival, and mobilization of bone marrow 
progenitor cells.  
The hypothesized role of endothelial NO deficiency in contributing to PH was further 
strengthened by the modest but healthy effects of inhaled NO and NO donors such as L-
arginine in patients with PH. NO stimulates the production of cGMP starting a regulatory 
cascade resulting in pulmonary vasodilatation. While inhaled NO is used as a clinical 
therapy only in patients with primary pulmonary hypertension of the newborn, sildenafil, 
an oral inhibitor of phosphodiestarase-5, has beneficial effects in both adult and childhood 
PAH, probably by means of increasing cyclic GMP through decreased breakdown (Sastry et 
al., 2004). 
Synthesis of NO involves incorporation of molecular oxygen, and hypoxia might therefore 
be expected to reduce NO release. A reduction in NO-mediated relaxation has been 
proposed as the underlying mechanism for HPV (Rodman et al., 1990), and hypoxia has 
been shown to inhibit agonist-stimulated release of NO in pulmonary arteries (Demiryurek 
et al. 1993). Inhibitors of NO synthesis potentiate HPV both in vivo and in perfused lungs 
(Sprague et al., 1992). It has been suggested that endogenous NO opposes HPV and thus 
limits the reduction in blood flow to the hypoxic alveoli (Sprague et al. 1992). Thus, the NO 
is clearly a major regulator of pulmonary vascular tone and may be important modulator 
during hypoxia. 
NO is synthesized endogenously by nitric oxide synthase (NOS) enzymes, which convert L-
arginine to L-citrulline and NO in the presence of oxygen, NADPH, flavin adenine 
dinucleotide, flavin adenine mononucleotide, tetrahydrobiopterin, and calmodulin 
(Knowles and Moncada, 1994). Three NOS enzymes have been so far identified in the lung. 
Neuronal NOS or NOS1 and endothelial NOS (eNOS) or NOS3 are primarily expressed in 
neuronal and vascular endothelial cells, respectively, of the normal lung, whereas the 
inducible NOS (iNOS) or NOS2 is expressed in the airway epithelium (Barnes and Belvisi, 
1993; Kobzik et al., 1993; Guo et al., 1995). Basal release of NO by isoform eNOS produces a 
consistent vasodilator and antimitogenic effect. Although eNOS is constitutively expressed, 
its expression can be modulated by a variety of chemical, physical, and developmental 
stimuli (Forstermann et al., 1998).  
The effects of eNOS-derived NO are mediated directly and via secondary messengers. In the 
presence of NO, guanylate cyclase becomes activated and produces cyclic guanosine 
monophosphate (cGMP) from guanosine triphosphate in the vascular smooth muscle. These 
two NO dependent routes resulting in calcium sequestration and smooth muscle relaxation 
(Jia et al., 1996; Moncada, 1993; McDonald and Murad, 1995; Rafikova et al., 2002; Stamler et 
al., 2001). Endothelial NO-induced vascular smooth muscle relaxation has been termed 
endothelium dependent. Exogenous NO donors, such as nitroglycerin, can cause 
endothelium-independent vascular smooth muscle relaxation. In particular, NO seems to be 
important for maintaining normal blood pressure and matching ventilation-perfusion within 
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the lung in broiler chickens. This concept is supported by the finding of Wang et al. (2002), 
who found that intravenous infusion of Nv-L-arginine-methyl-ester (L-NAME), which inhibits 
NO synthesis by both the eNOS and iNOS forms, caused an immediately reduced plasma 
concentration of NO and continuously increased pulmonary arterial pressure in healthy 
broilers. However, the L-NAME-induced increase in pulmonary pressure can be reversed by 
sodium nitroprusside, a nitric oxide donor (Weidong et al., 2002). 
Wideman et al (2006) suggested that pulmonary vasodilatation might be affected by the NO 
produced by iNOS in lungs exposed to an inflammatory stimulus. The endothelium 
dependent vasodilatation in chickens is partly mediated by NO, as reflected by the finding 
that L-NAME attenuates the concentration-dependent relaxation response of artery rings to 
acetylcholine (Martinez-Lemus et al., 1999). It has been considered that the endothelium-
dependent relaxation in the pulmonary artery of broilers is impaired, which contributes to 
the susceptibility of broilers to PH (Martinez-Lemus et al., 1999).  
In experimental studies the alteration of eNOS availability in PH was examined by exposing 
chickens to hypobaric hypoxia (Moreno de Sandino and Hernandez, 2003, 2006) and cold 
stress (Tan et al., 2007) to induce PH, right ventricular hypertrophy and pulmonary vascular 
remodeling, similar to that in natural PH cases. Those studies demonstrated that hypoxia-
induced as well as cold-induced PH was associated with reduced eNOS expression in the 
pulmonary arterioles, and that eNOS expression was inversely related to pulmonary 
vascular remodeling, strengthening the hypothesis of Martinez-Lemus et al. (1999) that 
impaired NO synthesis contributes to the susceptibility of chickens to PH. Giaid and Saleh 
(1995) reported decreased eNOS expression in human pulmonary vascular preparations and 
concluded that the reduction of this vasodilator enzyme contributed to the development of 
PH. Using eNOS-deficient rats, Steudel et al. (1998) confirmed that impaired eNOS-derived 
NO enhanced hypoxia-induced PH. NO levels in exhaled breath are reduced in the humans 
with IPAH, and there is an inverse relationship between NO in exhaled breath and the 
degree of PH (Kaneko et al., 1998; Machado et al., 2004; Girgis et al., 2005).  
The study by Richard et al. (1995) provided evidence that part of the hypertensive 
response in rats induced by inhibition of NO synthesis, which is generally considered to 
reflect removal of the tonic vasodilator influence of NO, is in fact due to the unmasking of 
an endothelin-induced vasoconstrictor response. With the progression of vascular disease 
and the gradual loss of the ability of vessels to dilate, vasoconstrictor processes can 
assume a greater importance, thereby causing further vascular dysfunction (Lavallee et 
al., 2001). In broilers, increased pulmonary pressure accompanied by elevated ET-1 
concentration was observed following inhibition of NO synthesis by supplemental L-
NAME to the diet (Wang et al., 2002). In this context, it is also probable that reduced 
production of the NO in hypertensive broilers may be only one manifestation of 
endothelial dysfunction, and that the vasoconstrictor role of the endothelium-derived 
vasoconstrictor ET-1 may become progressively important in the development of PH. 
Indeed, ETA receptor antagonist BQ123 has been shown to effectively prevent cold-
induced PH in broilers (Yang et al., 2005).  
Supplemental dietary L-arginine has been shown to reduce pulmonary arterial pressure as 
well as the incidence of PH in chickens exposed to cool environmental temperature without 
alteration of body weight (Wideman et al., 1995), and further studies revealed that dietary L-
arginine supplementation permitted broilers to exhibit flow-dependent pulmonary 
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vasodilatation when a pulmonary artery snare was tightened to force the entire cardiac 
output through one lung. Those findings were supportive of a NO vasodilator effect. Tan et al 
(2005a) showed that supplemental L-arginine markedly increased NO production in cold-
exposed broilers, coincident with reduced pulmonary blood pressure. This indicates that an 
increase in endogenous NO synthesis may relax the tone of the resistance vessels in the lung 
of broilers, thereby permitting the increased blood flow to pass through the lung at a lower 
pressure. Similarly, intravenous L-arginine was shown to reduce pulmonary arterial 
pressure in human patients with PH by increasing the endogenous production of NO 
(Mehta et al., 1995). In an in vitro study Eddahibi et al., (1992) provided evidence that L-
arginine restores endothelium-dependent relaxation of pulmonary vessels from 
hypertensive rats.  
Although the mechanisms for reduced expression of eNOS in hypertensive broilers remain 
to be identified, it has been considered reasonable to postulate that endothelium dysfunction 
significantly contributes to PH development through several mechanisms, including an 
imbalance between the release of vasoconstrictor agents like ET-1 and vasodilator 
substances such as prostacycline and NO (Adnot et al., 1991; Inagami et al., 1995: Stewart, 
1994; Tozzi and Riley, 1990; Voelkel and Tuder, 1995). A decrease in the amount of 
endothelium-dependent relaxation has been observed in pulmonary vessels from 
hypertensive animals, although its precise mechanism in the development of PH has not 
been established (Dhin-Xuan, et al., 1989, 1992; Martinez-Lemus et al., 1999). Some forms of 
hypertension might be due to changes in NO synthesis or action in the vasculature (Rees et 
al., 1989). Differences in endothelial NO synthesis are likely to be the result of various levels 
of genetically determined susceptibility to chronic hypoxia. Understanding the pathogenesis 
of PH and its key cellular and molecular mechanisms may allow manipulations to diminish 
the incidence of PH.  
Impairment of NO production in chronic hypoxia occurs in pulmonary hypertensive 
animals (Maruyama and Maruyama, 1994; Reddy et al., 1996;Tozzi and Riley, 1990) and 
humans (Cooper et al., 1996; Dinh-Xuan et al., 1992; Dinh- Xuan et al., 1989). However, the 
cause of this impairment remains unknown. A defect in NOS enzyme could cause reduction 
of NO production (Cooke et al., 1997; Huang et al., 1995). This hypothesis is supported by 
previous immunohistochemical analysis showing decreased expression of endothelial NOS 
(Giaid and Saleh, 1995). Alternatively, there may be inhibition of the enzymatic reaction of 
NO synthesis, due to deficiency of necessary cofactors or the L-arginine substrate (Ignarro, 
1990; Mitzutani and Layon, 1996; Shaul and Wells, 1994). NOS blockade has been shown to 
worsen hypoxia-induced PH, and administration of NO (in the inhaled air) ameliorates 
hypoxia-induced PH (Kouyoumdjian et al., 1994). In addition, L-arginine supplementation 
reduced right ventricular hypertrophy and mortality due to PH in male broilers exposed to 
low environmental temperatures (Wideman et al., 1995) and intravenous injections of L-
arginine reduced pulmonary arterial pressure in pulmonary hypertensive individuals by 
increasing endogenous production of NO (Mehta et al., 1995). L-arginine ameliorated 
changes associated with PH in rats, probably by enhancing endogenous NO production 
(Mitzutani and Layon, 1996).  
To determine whether or not exposure to chronic hypoxia and subsequent development of 
PH induce alterations in endothelial NO production in broiler’s pulmonary vascular bed, 
in our laboratory, we studied the expression of NOS in pulmonary endothelial cells in 
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healthy and hypertensive broilers raised at an altitude of 2638 m above sea level, using a 
nicotinamide adenine dinucleotide phosphate (NADPH)-diaphorase histochemical 
staining reaction. In this study, we demonstrated that NOS is present in pulmonary 
arterial endothelial cells of healthy and pulmonary hypertensive broilers. NOS activity is 
reduced in pulmonary arterial endothelial cells of pulmonary hypertensive broilers. 
Pulmonary hypertensive animals had lower numbers of pulmonary arterioles with 
NADPH-diaphorase-positive-staining endothelial cells than non-hypertensive chickens 
(healthy chickens) (Figures 4 and 5). Furthermore, the number of arterioles expressing 
NOS in the endothelial cells was inversely correlated with the degree of PH. The degree of 
PH was also significantly and inversely associated with NADPH-diaphorase positive 
staining. In fact, all hypertensive broilers had fewer arterioles expressing NOS in 
endothelial cells compared with the non-hypertensive broilers. This finding implies that 
hypertensive chickens show lower NO production than the non-hypertensive ones. 
Therefore, it is possible that NO participates in the pathogenesis of PH in broilers 
(Moreno de Sandino and Hernandez, 2003). Low L-arginine in the diet could provoke PH 
on its own or concomitantly with decreased NOS expression in hypertensive broilers. 
Although L-arginine content in feed in our study was not quantified, the diet used was 
presumed to be adequate in this context. 
The results of this work are in harmony with previous observations that the degree of PH 
was significantly and inversely associated with NOS inmunoreactivity (Giaid and Saleh, 
1995). Others demonstrated that hypoxia-induced PH is associated with a loss of NO 
activity in pulmonary vessels (Adnot and Raffestin, 1991). Other mediators, such ET-1, are 
also likely to be involved in the regulation of pulmonary vascular resistance (Giaid, 1998; 
Giaid et al., 1993; Stewart, 1994; Stewart et al., 1991). Interactions among mediators and NO 
may be important.  
Endothelial-derived NO production or activity or both are reduced in certain forms of 
chronic PH in several experimental animal models and in humans. Whether this impairment 
causes the disease, or merely reflects its severity remains to be elucidated. Hence, NO 
formation by pulmonary endothelial cells may represent a primary event in the 
pathogenesis of PH (Moreno de Sandino and Hernández, 2003). 
Recent research (Tan et al., 2007) demonstrated that loss of eNOS expression could be 
prevented by supplemental L-arginine. This finding probably reflects the ability of L-
arginine to ameliorate haemodynamic damage to the pulmonary endothelium in 
hypertensive broilers, and provides a proof that supplemental L-arginine increasing NO 
production is associated with elevated eNOS expression. Supplemental L-arginine reduced 
but did not eliminate mortality due to PH (Wideman et al., 1995; Tan et al., 2007), indicating 
that treatment with L-arginine reduced pulmonary pressure only to a certain extent. In one 
case, however, supplemental L-arginine did not affect PH mortality (Ruiz-Feria et al., 2001). 
It is well known that PH in fast-growing broilers is a complex, multi-factorial process. In 
addition to vascular dysfunction (e.g. remodeling and impaired endothelium-dependent 
relaxation), causes that may affect pulmonary pressure include an inherently low 
pulmonary vascular capacity, inadequate gas exchange area for blood cells, and a cardiac 
output that chronically increases in support of metabolic requirements (Wideman and 
Tackett, 2000; Wideman, 2001; Hassanzadeh et al., 2005). Therefore, it is difficult to eliminate 
PH in broilers solely by supplemental L-arginine. 
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Fig. 4. Endothelium NADPH-diaphorase positive reaction of pulmonary arteriole (Moreno 
de Sandino and Hernández, 2003). 
 
Fig. 5. Endothelium NADPH-diaphorase negative reaction of pulmonary arteriole (Moreno 
de Sandino and Hernández, 2003). 
Several lines of evidence support a major role for NO and in particular for eNOS in the 
pulmonary circulation: 
1. eNOS-deficient mice had mild PH (pulmonary artery pressure 19.0 ± 0.8 compared with 
16.4 ± 0.6 mmHg in wild-type mice). In the same study, isolated pulmonary arteries of 
NOS3-deficient mice failed to show the normal vasodilator response to acetylcholine but 
were morphologically unaltered (Steudel et al., 1997).  
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2. In a complementary study by the same group of investigators, mice with congenital 
deficiency of eNOS (which exhibit major systemic and mild PH under normoxic 
conditions) developed more severe degrees of PH after a 3- to 6-wk period of hypoxia 
(11% oxygen). The NOS-deficient mice also showed greater increases in vascular 
remodeling and right ventricular hypertrophy than wild-type mice, and right 
ventricular hypertrophy was prevented by breathing at 20 parts per million NO (Steudel 
et al., 1997).  
3. Deletion of the eNOS gene was associated with histological evidence of PH in both male 
and female mice during fetal life and at birth, but PH and right ventricular hypertrophy 
persisted only in the adult males. In neither sex did inducible or neuronal NOS 
compensate for the deletion of eNOS (Miller et al., 2005).  
4. Lung tissue from patients with chronic PH showed decreased eNOS expression in 
vascular endothelium, especially in patients with severe histological abnormalities (i.e., 
with plexiform lesions); the intensity of the enzyme immunoreactivity correlated 
inversely with the severity of histological changes. The findings support the conclusion 
that the reduction of this vasodilator enzyme may contribute to the development of PH 
(Giaid A and Saleh, 1995).  
5. Consistent with the above conclusion, mice deficient in the de novo production of 
tetrahydrobiopterin (BH4), a cofactor for NOS, selectively express a pulmonary 
hypertensive, but not systemic hypertensive phenotype (Nandi et al., 2005).  
6. Inhaled NO attenuated PH and improved lung growth in infant rats after neonatal 
treatment with a VEGF receptor inhibitor (Tang et al., 2004).  
7. In chickens reared at high altitude, NOS expression is lower in the endothelial cells of 
pulmonary arteries of hypertensive chickens compared with nonhypertensive chickens 
(healthy subjects) and lower NOS expression was associated with medial smooth 
muscle thickening (Moreno de Sandino and Hernández, 2003, 2006. See figures 4 and 5) 
8. In chickens reared at high altitude, NOS mRNA expression is lower in the lungs of 
hypertensive chickens compared with nonhypertensive chickens (healthy subjects), and 
lower NOS mRNA expression was associated with medial smooth muscle thickening 
(non-published data). 
4.1.2 Endothelin- 1  
Endothelin (ET-1) is a family of four 21-amino-acid peptides (ET-1, ET-2, ET-3, ET-4). Of the 
four active endothelins, ET-1 is the predominant isoform in the cardiovascular system, 
which is generated through the cleavage of prepro-ET-1 to big ET-1 and then to ET-1 by the 
action of endothelin-converting enzymes (ECE). ET-1 is abundantly expressed in human 
lung´s vasculature and plays an important role in pulmonary vascular tone regulation 
(Giaid et al., 1993; Kourembanas et al., 1993). In mammals, both pulmonary vascular 
endothelial cells and vascular smooth muscle cells synthesize and release ET-1 (Wort et al., 
2001). The vascular effects of ET-1 are mediated by two receptor types: ET receptor subtype 
A (ETA) and ET receptor subtype B (ETB) (Luscher and Barton, 2000). The ETA receptors are 
expressed on pulmonary vascular smooth muscle cells, while ETB receptors are located on 
both pulmonary vascular endothelial cells and smooth muscle cells. Stimulation of ETA 
receptors results in vasoconstriction and cell proliferation, whereas ETB receptors on the 
endothelial cells mediate clearance of ET-1, inhibition of endothelial cell apoptosis, release of 
NO and prostacyclin, and inhibit the expression of ECE-1. However, there is evidence that 
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the ETB receptors on smooth muscle cells may also play a major role in mediating ET-1-
induced constriction of intrapulmonary conduit and resistance arteries in humans and rats 
(Wang et al., 2006; Sakurai et al., 1990). 
Through its action on the endothelin receptor A (ETA) on pulmonary artery smooth muscle 
cells, ET-1 leads to a rapid increase in intracellular calcium and sustained activation of 
protein kinase C. Early activation of the p42/p44 isoforms of mitogen-activated protein 
kinase and induction of the early growth response genes c-fos and c-jun are also observed 
(Jeffery and Morrell 2002). The mitogenic action of ET-1 on pulmonary artery smooth muscle 
cells occurs through the ETA or endothelin receptor B (ETB) subtype, depending on the 
anatomic location of cells. For instance, ETA mediates mitogenesis in cells derived from the 
main pulmonary artery, whereas in cells from resistance arteries both receptor subtypes may 
contribute. There is strong evidence that endothelium-derived ET-1 is a major player in the 
vasodilator/vasoconstrictor imbalance characteristic of PH. Levels of lung and circulating 
ET-1 are increased in animals and patients with PH of various etiologies (Giaid et al., 1993). 
These observations indicate that ET-1 is likely to contribute to the vasoactive component of 
PH, as well as to the abnormal pulmonary vascular remodeling characteristic of the 
condition. Results of chronic ET receptor antagonist therapy support the relevance of this 
pathway in PH.  
ET-1 is a potent vasoconstrictor peptide, and hypoxia has been demonstrated to increase ET-
1 gene expression and secretion in cultured endothelial cells (Kourembanas et al., 1991). A 
study by Wang et al., (1995) has shown that the ET-1 antagonist BQ-123 can inhibit HPV in 
fetal lambs, but it is worth noting that the decline to baseline tension on return to normoxia 
was slow in this preparation. Although a role for ET-1 in HPV cannot be ruled out, it is more 
likely to be of importance in chronic hypoxia and it may well be involved in mediating some 
aspects of the pulmonary vascular remodelling seen under these conditions. 
Gómez et al (2007, 2008), Davie et al (2002), Giaid et al (1993), Motte et al (2006)  
and Stewart et al (1991) showed convincing evidence which suggests that local ET-1 
synthesis in vascular endothelial cells probably plays an important role in the 
pathophysiology of PH:  
1. ET-1-like immunoreactivity and messenger RNA, rarely present in vascular endothelial 
cells from control subjects, were abundant in IPAH patients and were associated with 
medial thickening and intimal fibrosis.  
2. There was a strong correlation between the intensity of ET-1-like immunoreactivity and 
pulmonary vascular resistance in patients with plexogenic pulmonary arteriopathy, but 
not in those with secondary PH.  
3. ET-1 receptor density was considerably greater in smaller pulmonary arteries and lung 
parenchyma from pulmonary hypertensive patients than in control subjects.  
4. ET-1 stimulated DNA synthesis in human PA smooth muscle cells.  
5. Inhibition of endogenous ET-1 release or its action attenuated serum-stimulated 
proliferation of pulmonary vascular smooth muscle cells.  
6. ET-1 mRNA expression is higher in the lung of pulmonary hypertensive chickens at 
high altitude compared with nonhypertensive chickens (healthy subjects), and high ET-
1 mRNA expression was associated with medial smooth muscle thickness (Gómez et al., 
2007, 2008).  
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7. In addition, studies have shown enhanced ET-1 and ECE-1 synthesis in humans and 
experimental animals with primary IPAH (Giaid et al., 1993; Giaid, 1998). 
Similarly, increased ET-1 mRNA level in the lung of broilers with PH induced by chronic 
hypobaric hypoxia was observed in our laboratory; comprehensive gene expression 
analysis was performed in the lung of broilers under chronic hypobaric hypoxic 
conditions by using real-time PCR analysis. In this study, it was shown for the first time 
that ET-1 mRNA expression is higher in the lung of pulmonary hypertensive broilers 
(PHB) than nonhypertensive broilers (NPHB) (Figures 6,7 and 8; Gómez et al., 2007). This 
result is in agreement with previous observations made in humans and in induced PH in 
various animal models (Mortensen and Fink, 1992; Rabelink et al., 1994; Potter et al., 1997; 
Cardillo et al., 1999), in which it has been shown that ET-1 could be involved in the 
pathogenesis of PH. ET-1 induces vasoconstriction, promotes fibrosis, has mitogenic 
potential, and is important in the regulation of vascular tone, arterial remodeling, and 
vascular injury. However, its role in normal cardiovascular homeostasis and PH is unclear 
(Touyz and Schiffrin, 2003).  
Contrary to previous reports in the lungs of hypoxic rats (Li et al., 1994) and in cells from the 
pulmonary artery of PH sheep (Balyakina et al., 2002), our work showed a decrease in ETA 
mRNA levels in the lungs of PHB (Figure 5). Thus, HPB showed high values of mRNA ET-1 
and lowest values of mRNA of eNOS, and NHPB had opposite results (data non published). 
In studies with ET-1 receptors antagonists, differences were found in expression levels, 
according to the experimental models used (McCulloch and MacLean, 1995; Maxwell et al., 
1998; Luscher and Barton, 2000). The distribution and density of ET-1 receptors on vascular 
SMC varies among species and their location in the corresponding blood vessel (Nishimura 
et al., 1995; Chen and Oparil, 2000; Balyakina et al., 2002). Nevertheless, the role of ET-1 
receptors that mediate the vasoconstrictor response in this animal model requires further 
study.  
 
 
 
Fig. 6. Representative reverse-transcription PCR (RT-PCR) for hypoxanthine 
phosphoribosyltransferase (HPRT; 179 bp), endothelin 1 (ET-1; 141 bp), ET receptor type A 
(ETA; 160 bp), adrenomedullin (AM; 190 bp), connective tissue growth factor (CTGF; 252 
bp), and platelet-derived growth factor (PDGF; 200 bp) mRNA in lung samples from 
nonhypertensive broilers at 24 d old. A 100-bp molecular weight marker (M) was used. The 
PCR products were separated on 1.5% agarose gel, stained with ethidium bromide and 
examined with ultraviolet light and visualized with a Gel Doc system (Bio-Rad, Hercules, 
CA). In addition, negative controls are shown and resulted in no bands after amplification 
(Gómez et al., 2007).  
www.intechopen.com
 Pulmonary Hypertension – From Bench Research to Clinical Challenges 128 
Several studies have demonstrated the interaction between NO and ET-1 in the vascular 
endothelium in mammals. NO mitigates the vasopressor activity of ET-1 (Filep et al., 1993), 
inhibits translation of prepro-ET-1 mRNA (Bodi et al., 1995), augments the degradation of 
ET-1 protein, and reduces ET-1 formation (Kourembanas et al., 1993). A number of 
vasculopathies associated with impaired bioavailability of NO are linked to increased ET-1 
synthesis (Alonso and Radomski, 2003). 
 
 
 
Fig. 7. Comparison by using real-time reverse-transcription PCR analysis of lung endothelin 
1 (ET-1) mRNA levels in non-pulmonary hypertensive and pulmonary hypertensive 
chickens subjected to chronic hypobaric hypoxia. Semiquantitative data of ET-1 mRNA 
expression levels were normalized to those of the internal control hypoxanthine 
phosphoribosyltransferase (HPRT). Data are represented as mean ± SEM (n = 15/group). 
***P < 0.001 (Gómez et al., 2007).  
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Fig. 8. Relative quantification of the regulation of lung endothelin type A (ETA) mRNA 
expression in pulmonary hypertensive and non-pulmonary hypertensive chickens subjected 
to chronic hypobaric hypoxia by using real-time reverse-transcription PCR analysis. Data of 
ETA mRNA expression levels were normalized to those of the internal control hypoxanthine 
phosphoribosyltransferase (HPRT). Data are represented as mean ± SEM (n = 15/group). 
***P <0.001 (Gómez et al., 2007). 
4.1.3 Potassium channels 
Lessons relevant to PH can be learned from understanding the mechanism of HPV, although 
PH also involves cell proliferation and abnormalities of apoptosis (Archer and Rich, 2000). 
HPV is elicited when hypoxia inhibits one or more voltage-gated potassium channels (Kv) in 
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the pulmonary artery smooth muscle cells of resistance pulmonary arteries. The resulting 
membrane depolarization increases the opening of voltage-gated calcium channels, raising 
cytosolic calcium and initiating constriction. The Kv1.5 is downregulated in pulmonary 
artery smooth muscle cells in humans with PH (Yuan et al., 1998), and both Kv1.5 and Kv2.1 
are downregulated in rats with chronic hypoxia-induced pulmonary hypertension 
(Michelakis et al., 2002).  
Furthermore, deoxyribonucleic acid microarray studies have shown downregulation of Kv 
channel genes in PH lungs (Geraci et al., 2001; Weir and Olschewiski, 2006). The selective loss 
of these Kv channels leads to pulmonary artery smooth muscle cell depolarization, an increase 
in the intracellular calcium, and both vasoconstriction and cell proliferation. It is not clear 
whether these Kv channel abnormalities are genetically determined or acquired. However, it is 
clear that the appetite suppressants dexfenfluramine and aminorex directly inhibit Kv1.5 and 
Kv2.1 (Weir et al., 1996). Augmenting Kv pathways should cause pulmonary vasodilation and 
promote regression of pulmonary remodeling. Drugs including dichloroacetate and sildenafil 
may enhance the expression and function of these potassium channels.  
4-Aminopyridine (4-AP), an inhibitor of Kv channels, but not ATP-sensitive K+ channels, 
causes pulmonary vasoconstriction (Hasunuma et al., 1991). Post et al. (1992) showed that 
hypoxia inhibited K+ current (IK) and depolarized membrane (EM) in canine PASMCs. This 
initiated extensive research to quantify the contribution of K+ channels to HPV and 
determine the molecular identity of the O2-sensitive K+ channels. K+ channels are proteins 
consisting of four transmembrane-bound -subunits and four regulatory -subunits. The 
ionic pore which determines the channel's intrinsic conductance and ionic specificity is 
created by the formation of tetramers of -subunits. The Kv channels also have a voltage 
sensor in their S4 region. -Subunits associate with many K+ channels and alter their 
expression and kinetics. There are several types of K+ channel -subunits, including Kv, 
inward rectifier, and twin pore channels. The Kv channels have emerged as a possible 
effector in HPV (Reeve et al., 2001).  
Kv channels are important determinants of equilibrium potential of vascular SMCs. Closure 
of Kv channels decreases the tonic efflux of K+ that otherwise occurs because of the intra-
/extracellular concentration gradient (145/5 mM). Channel closure renders the cell interior 
relatively more positive (depolarized). At these more positive potentials (positive to –30 
mV), the probability of L-type voltage-gated Ca2+ channels to open increases. This augments 
intracellular Ca2+ influx (down a 20,000/1 concentration gradient). Although less important 
than in cardiomyocytes, Ca2+ influx also cause release of intracellular stores, so-called 
calcium-induced calcium release, effectively increasing total calcium levels inside the cell. 
Increased cytosolic Ca2+ activates contraction via the actin-myosin apparatus and also 
increases the activation of immediate early genes, inducing a proliferative response 
(Platoshyn et al., 2000). Thus, regulation of K+ channel activity and the subsequent 
regulation of Ca2+ may be important to maintain the pulmonary circulation's low PVR and 
the thin-walled morphology of small pulmonary arteries.  
Although all K+ channels are somewhat sensitive to prolonged or severe O2 deprivation 
(because most require some basal phosphorylation and thus ATP), certain K+ channels are 
specially suited to O2 sensing, by virtue of their content of key cysteine and methionine 
groups. Reduction or oxidation of these residues by a redox mediator such as ROS can cause 
conformational changes in the channel, thereby altering pore function (Archer et al.,1998). In 
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this regard, some Kv channels, including Kv1.5, respond to reduction and oxidation by 
changing their gating and open-state probability (Archer et al., 1998).  
Hypoxia and redox agents may alter the function of K+ channels, directly (Jiang and 
Haddad, 1994) or by modulating the levels of ROS, a diffusible redox mediator. It is 
unknown whether the electrophysiological effects of O2 act directly or through a redox 
mediator. However, for a channel to respond to a diffusible redox mediator, it probably 
must be intrinsically redox sensitive.  
Nine families of Kv channel have been identified, each with multiple isoforms. These 
channels activate in a nonlinear fashion with depolarization and many are inhibited by the 
pore-blocking drug 4-AP. A variety of putative O2-sensitive channels exist in the PASMCs 
(Kv1.2, Kv1.5, Kv2.1, Kv3.1b, and Kv9.3) (Coppock et al., 2001). The importance of Kv1.5 and 
Kv2.1, 4-AP-, and redox-sensitive channels is emphasized by two models that manifest 
selective suppression of HPV: the chronic hypoxic hypertension model and the Kv1.5 
knockout mouse.  
In chronic hypoxia, impairment of HPV results from loss of Kv1.5, and to a lesser extent 
Kv2.1, expression with concordant suppression of O2-sensitive IK (Reeve et al., 2001). In 
chronic hypoxia, enhancing expression of Kv1.5 via Kv1.5 adenoviral gene transfer (Pozeg et 
al., 2003) restores Kv expression, O2-sensitive IK, and HPV. Mice with targeted Kv1.5 
deletions also have impaired HPV and reduced PASMC O2-sensitive IK (Archer et al., 2001).  
Archer et al. (2004) showed that preconstriction with the Kv blocker 4-AP eliminates 
subsequent HPV, although the pulmonary artery constricts vigorously to phenylephrine 
under the same conditions. The strong parallel between constriction to the selective Kv1.x 
channel inhibitor correolide and hypoxia suggests that a Kv1.x channel is central to the 
mechanism of HPV (Archer et al. 2004). Theoretically, correolide can inhibit Kv1.2; however, 
tityustoxin, an inhibitor of Kv1.2/Kv1.3, inhibits only a small portion of the hypoxia-sensitive 
IK (Archer et al. 2004). Moreover, intracellular dialysis of PASMCs with antibodies against 
intracellular domains of Kv1.5 causes membrane depolarization and the combination of anti-
Kv1.5 and anti-Kv2.1 blunts responsiveness to hypoxia (Archer et al., 1998, Archer et al. 
2004). Finally, although mRNA of many Kv channels is more abundant in resistance vs. 
conduit pulmonary arteries, only Kv1.5 protein is expressed more abundantly in resistance 
pulmonary arteries, which are the main locus for HPV (Archer et al., 2004).  
Human Kv1.5, cloned from normal pulmonary artery, generates an outward Kv current at –
65 mV, which is inhibited by hypoxia (Archer et al., 2004). Thus the consequence of enriched 
Kv1.5 expression in resistance pulmonary arteries is a relative hyperpolarization of resistance 
vs. conduit pulmonary artery smooth muscle cells ( –60 vs. –35 mV) (Archer et al., 2004).  
Intracellular Ca2+ plays an obligatory role in pulmonary vasoconstriction (Gelband and 
Gelband, 1997, Salvaterra and Goldman, 1993); the question is the extent to which influx of 
extracellular Ca2+ vs. release of intracellular Ca2+ initiates HPV. There is no doubt that, as in 
all types of smooth muscle cells, release of Ca2+ from intracellular pools, particularly the SR, 
is important to vasoconstriction. As with the differential function of O2-sensitive Kv channels 
in pulmonary artery vs. renal arteries, there are differences in handling of intracellular Ca2+ 
between SMCs in these circulations. In PASMCs, inositol triphosphate (IP3) and ryanodine-
sensitive Ca2+ stores are organized into spatially distinct compartments. 
www.intechopen.com
 Pulmonary Hypertension – From Bench Research to Clinical Challenges 132 
Hypoxia causes intracellular Ca2+ increase, reaching maximum level in 1–2 min, and this is 
sustained during hypoxia, reversing on return to normoxia (Robertson et al., 2000). Urena et 
al. (1996) found that in conduit pulmonary artery smooth muscle cell, hypoxia reduced basal 
intracellular Ca2+ and decreased Ca2+ spikes (Urena et al., 1996), consistent with the lack of 
significant HPV in conduit pulmonary arteries (Archer et al., 1996). In resistance pulmonary 
arteries, two subsets of PASMCs were identified, one in which hypoxia increased cytosolic 
Ca2+, a response mimicked by KCl and inhibited by nifedipine, or the removal of 
extracellular Ca2+, and another in which hypoxia decreased Ca2+ (Urena et al., 1996). These 
findings of longitudinal heterogeneity in Ca2+ homeostasis are in keeping with the 
previously identified K+ channel diversity in the pulmonary circulation (Albarwani et al., 
1995; Archer et al., 1996). Nonetheless, the predominant source of Ca2+ for HPV appears to 
be extracellular and it enters the PASMCs via the L-type Ca2+ channels. For example, in 300-
µm pulmonary arteries, hypoxia (PO2 30–50 Torr) causes vasoconstriction and increases 
intracellular Ca2+ (Harder et al., 1985), both of which were blocked by verapamil, as occurs 
in humans (Burghuber, 1987) and rodents (McMurtry et al., 1976).  
In conclusion, ionic channels play an important role in response to hypoxia in the 
pulmonary arteries. In addition to responding to membrane depolarization by hypoxia, 
there is an increase of calcium influx in the pulmonary artery via the L-type Ca channel 
which signal further release of calcium from the sarcoplasmic reticulum. Clearly, hypoxia 
increases calcium entry through stored-operated channels (SOCs), enhances calcium 
sensitivity, and increases vascular smooth muscle contraction and proliferation (Weir et al., 
2005; Weir et al., 2006) 
5. Pulmonary vascular remodeling 
The pulmonary circulation is a low-pressure, high-flow system with a great capacity for 
recruitment of normally unperfused vessels. As a consequence, the walls of pulmonary 
arteries are thin, in keeping with their low transmural pressure. PH is a disease of the small 
pulmonary arteries, characterized by vascular narrowing and thickening, leading to a 
progressive increase in pulmonary vascular resistance. The consequence of this increased 
right ventricle afterload is the failure of the after load-intolerant right ventricle. The vascular 
remodeling is characterized by hypertrophy of the vascular media and the extension of 
smooth muscle to previously unmuscularized pulmonary arterioles (Hislop and Reid, 1976; 
Reid, 1979; Stenmark and Mecham, 1997). The process of pulmonary vascular remodeling 
involves all layers of the vessel wall and is complicated by the cellular heterogeneity which 
exists within the compartment of the pulmonary arterial wall (Jeffery et al., 2002). Indeed, 
each cell type (endothelial, smooth muscle, and fibroblast), as well as inflammatory cells and 
platelets, may play a significant role in PH. There is endothelial cell injury, migration of 
smooth muscle cells into the subintima, thickening of the medial layer, and increased 
production of collagen and elastin within the vessel wall (Gibbons and Dzau, 1994). Similar 
pathological changes are shown in most, if not all, broilers with chronic PH (Enkvetchakul 
et al., 1995; Xiang et al., 2002). Many factors are involved in the remodeling response in PH 
in humans and experimental animals (Jeffery and Wanstall, 2001). 
In order to determine whether pulmonary arteriolar remodeling is related to eNOS expression 
in the vascular pulmonary bed of hypoxia-induced PH in broiler chickens, we investigated 
NOS expression and remodeling in lung vessels of hypertensive and nonhypertensive broilers 
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reared at high altitude (2638 masl). In this study, we demonstrated that normal broilers 
expressed greater amounts of NOS than PH broilers, and that NOS expression was inversely 
associated with vascular remodeling. PH broilers had thicker muscular and adventitial layers 
in pulmonary arterioles when compared with normotensive ones (Figures 9 and 10). We 
concluded that hypoxia-induced remodeling of pulmonary arterioles in broiler chickens 
appears to be associated with decreased endothelial NO production (Moreno de Sandino and 
Hernandez, 2006); the inhibition effect might be associated with decreased NO-induced 
apoptosis in PASMCs (Tan et al., 2005a). We concluded that the vascular remodeling could be 
mediated, at least in part, by decreased NO release by endothelial cells (Moreno de Sandino 
and Hernandez, 2006; Stenmark and Mecham, 1997).  
Recent studies demonstrated that supplemental L-arginine inhibited remodeling in 
hypertensive broilers, an effect associated with NO-induced apoptosis of smooth muscle cells 
(Tan et al., 2005a) and NO-induced loss of expression of protein kinase C (Tan et al., 2006) in 
pulmonary arterioles. Other mechanisms involved in this process might include the direct 
anti-mitogenic effect of NO on smooth muscle cells (Thomae et al., 1995), NO-induced loss of 
production or expression in vasoconstrictors and mitogens such as ET-1 and platelet-derived 
growth factor (Kourembanas et al., 1993), and NO-induced loss of MMP activity in the lung 
(Souza-Costa et al., 2005). However, these mechanisms remain to be studied in broilers. 
 
 
Fig. 9. Non-hypertensive chicken’s arteriole. Thin smooth muscular (stained in red and 
indicated by black lines) and adventitial (dark blue) layers. Masson trichromic-stained. 
Hypoxic arterial remodeling includes proliferation and migration of PASMCs. Platelet 
derived growth factor (PDGF) has also been implicated in these processes. Schermuly et al. 
(2005) found that administration of STI571, a PDGF receptor inhibitor, reversed pulmonary 
vascular changes in hypoxia-induced PH. Conversely, we did not find differences in PDGF 
mRNA expression levels between PH broilers and their controls (Gómez et al., 2007).  
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Fig. 10. Hypertensive chicken´s arteriole. Thick smooth muscular (stained in red and 
indicated by black lines) and surrounding adventitial (stained in dark blue) layers. Masson 
trichromic stain. 
ET-1 participates in remodeling by increasing the connective tissue growth factor (CTGF) 
mRNA expression, promoter activity, and protein production (Rodriguez-Vita et al., 2005). 
CTGF regulates cell proliferation and apoptosis, angiogenesis, migration, adhesion, and 
fibrosis (Brigstock, 1999; Perbal, 2004). In order to determine if CTGF is involved in the PH 
in chickens, we investigated the CTGFmRNA in hypoxic hypertensive chickens and non 
hypertensive broilers reared in altitude (2638 masl). We demonstrated an increase in the 
CTGF mRNA expression levels in hypertensive chickens, which suggests that CTGF could 
be a mediator of fibrotic effects of ET-1 in hypoxic PH (Gómez et al., 2007). Some 
investigators suggest that the CTGF might be considered as a new target for therapeutic 
interventions in PH (Rodriguez-Vita et al., 2005). This is supported by the results of our 
work (Gómez et al., 2007).  
Adrenomedullin (AM) is a potent vasodilator peptide that was originally isolated from human 
pheochromocytoma (Kitamura et al., 1993). Immunoreactive AM has subsequently been 
detected in plasma and in a variety of tissues, including blood vessels and lungs (Ichiki et al., 
1994; Sakata et al., 1994). It has been reported that there are abundant binding sites for AM in 
the lungs. Owji et al., 1995; Kakishita et al.,1999; Yoshibayashi et al., 1997 have shown that the 
plasma AM level increases in proportion to the severity of PH and that circulating AM is 
partially metabolized in the lungs. Interestingly, AM has been shown to inhibit the migration 
and proliferation of vascular smooth muscle cells (Horio et al., 1995; Kano et al., 1996). These 
findings suggest that AM plays an important role in the regulation of pulmonary vascular tone 
and vascular remodeling. In fact, experimental studies (Heaton et al., 1995; Nossaman et al., 
1996) have demonstrated that intralobar arterial infusion of AM induces pulmonary 
vasodilation in rats and cats. In humans, short-term intravenous infusion of AM significantly 
decreases pulmonary vascular resistance in patients with congestive heart failure (Nagaya et 
al., 2000a) or IPAH (Nagaya et al., 2000). Intravenously administered AM also decreases 
systemic arterial pressure in such patients, as well as in experimental models of PH (Nagaya et 
al., 1999, 2000, 2005; Nishikimi et al., 2003; Okumura et al., 2004), via a nonselective 
vasodilation of pulmonary and systemic vascular beds. 
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Nagaya et al (2003) showed that repeated inhalation of AM inhibited monocrotaline-
induced pulmonary hypertension without systemic hypotension and improved survival in 
rats. Thus, they suggest that the long-term treatment with aerosolized AM may be a new 
therapeutic strategy for the treatment of PH. 
We and others also showed that AM mRNA expression is decreased in pulmonary 
hypertensive broilers compared with non-hypertensive chickens (Gómez et al., 2007; 
Nakayama et al., 1998; Wang et al., 2001; Xu et al., 2002).  
Adrenomedullin actives the PI3K/Akt-dependent pathway in vascular endothelial cells 
(Nishimatsu et al., 2001), which is considered to regulate angiogenesis (Jiang et al., 2000). In 
an in vitro study, AM was upregulated by the hypoxia inducible factor-1 under hypoxic 
conditions (Garayoa et al., 2000). These results suggest that hypoxia simulates AM synthesis, 
which plays an important regulatory role in pulmonary circulation and vascular remodeling 
(Wang et al., 2001) and represents a compensatory mechanism as an angiogenic factor 
promoting neovascularization under hypoxic conditions (Nagaya et al., 2005). 
It should be noted that several other molecules appear to participate in the vascular response 
to hypoxia, such as serotonin (Chapman and Wideman, 2002) and thromboxane (Wideman et 
al., 1999), nuclear factor, interleukin-6, and early growth response-1 (Semenza, 2000).  
Although little is known about the pathogenesis of remodeling in hypertensive broilers, 
evidence is emerging that there is reduced apoptosis in vascular smooth muscle cells (Tan et 
al., 2005a) and increased expression of protein kinase C (Tan et al., 2005b), a key enzyme in 
promoting the proliferation and differentiation of vascular smooth muscle cells and non-
muscle cells (Assender et al., 1994; Haller et al., 1995; Wang et al., 1997; Fleming et al., 1998). 
Additionally, using an immunohistochemical technique, Ozyigit et al. (2005) found that the 
expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors of 
metalloproteinase (TIMP)-1 were increased in the lung of broilers with salt-induced PHS, 
and that MMP-2 was localized mainly in pulmonary vascular endothelium whereas TIMP-1 
was localized in the adventitia. MMPs are matrix-degrading enzymes involved in 
extracellular matrix turnover, smooth muscle cell and endothelial cell migration and 
proliferation. Increased MMP-2 activity in the pulmonary vessels of hypoxic rats was shown 
to be associated with the severity of PH (Frisdal et al., 2001). In addition, Herget et al. (2003) 
reported that inhibition of MMP activity attenuated pulmonary vascular remodeling as well 
as hypertension in chronically hypoxic rats, and suggested that the increased MMP activity 
might represent a substantial factor mediating the effect of hypoxia on the development of 
PH. Another study by Lepetit et al. (2005) demonstrated an imbalance between MMP-3 and 
TIMP-1 expression and an increase in MMP-2 expression in pulmonary arterial smooth 
muscle cells from patients with IPAH. These authors speculated that the imbalance between 
MMP-3 and TIMP-1 might lead to extracellular matrix accumulation and that the increased 
MMP-2 expression contributes to smooth muscle cell migration and proliferation (Lepetit et 
al., 2005). In this context, the results from mammals are indicative that the development of 
pulmonary vascular remodeling in hypertensive broilers may be related to alterations in the 
expression of MMPs and their TIMPs (e.g., MMP-2 and TIMP-1). However, definitive 
studies need to be designed to test this hypothesis.  
Vascular remodeling will contribute to a sustained elevation in pulmonary arterial pressure 
and become progressively important as the disease advances because of an increased 
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pulmonary vascular resistance to blood flow and a decreased vascular compliance response. 
Therefore, inhibiting remodeling may be an important approach for prevention in PH 
(Jeffery et al., 2001). The development of a resistant genetic strain of commercial chickens to 
hypobaric hypoxia as a long-term goal should be a coherent strategy to diminish PH in 
chickens, with a concomitant economic impact. Furthermore, the avian model has been 
accepted as a model to study PH in mammals. Hence, future research is expected to support 
pharmacological approaches to be applied in another animal species, including man. 
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